Apoptosis and schizophrenia: Is the tumour suppressor gene, p53, a candidate susceptibility gene?

Schizophrenia Research

Volumn 41, Issue 3, 2000, Pages 405-415

  Catts, Vibeke Sørensen ^a   Catts, Stanley Victor ^b  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Apoptosis; Cancer; Candidate gene; p53; Schizophrenia

Indexed keywords

PROTEIN P53;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; CANCER RISK; CANCER SUSCEPTIBILITY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BRAIN; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; NEOPLASMS; RISK; SCHIZOPHRENIA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033975582     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00077-8     Document Type: Article

References (62)

1. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney W.E., Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch. Gen. Psychiatry. 53:1996;425-436.
2. Allebeck P., Wistedt B. Mortality in schizophrenia. Arch. Gen. Psychiatry. 43:1986;650-653.
3. Andreasen N.C. The role of the thalamus in schizophrenia. Can. J. Psychiatry. 42:1997;27-33.
4. Armstrong E., Curtis M., Buxhoeveden D.P., Fregoe C., Zilles K., Casanova M., McCarthy W.F. Cortical gyrification in the rhesus monkey: a test of the mechanical folding hypothesis. Cereb. Cortex. 1:1991;426-432.
5. Armstrong E., Schleicher A., Omran H., Curtis M., Zilles K. The ontogeny of human gyrification. Cereb. Cortex. 5:1995;56-63.
6. Baldwin J.A. Schizophrenia and physical disease. Psychol. Med. 9:1979;611-618.
7. Baldwin J.A. Schizophrenia and physical disease. Hemmings G. The Biochemistry of Schizophrenia and Addiction. 1980;297-317 MTP Press, Lancaster.
8. Benes F.M., Davidson J., Bird E.D. Quantitative cytoarhitectural studies of the cerebral cortex of schizophrenics. Arch. Gen. Psychiatry. 43:1986;31-35.
9. Burkhalter A., Bernardo K.L., Charles V. Development of local circuits in human visual cortex. J. Neurosci. 13:1993;1916-1931.
10. Catts S.V., Ward P.B., Lloyd A., Huang X.F., Dixon G., Chahl L., Harper C., Wakefield D. Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia. Aust. New Zealand J. Psychiatry. 31:1997;17-26.
11. de Leon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., Simpson G.M. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry. 152:1995;453-455.
12. Dupont A., Jensen O.M., Strömgren E., Jablensky A. Incidence of cancer in patients diagnosed as schizophrenic in Denmark. ten Horn G.H.M.M., Giel R., Gulbinat W.H., Henderson J.H. Psychiatric Case Registers in Public Health. 1986;229-239 Elsevier, Amsterdam.
13. Falkai P., Bogerts B. The neuropathology of schizophrenia. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;Blackwell Science, Cambridge. (Chapter 15).
14. Ferrer I., Soriano E., Del Rio J.A., Alcántara A., Auladell C. Cell death and removal in the cerebral cortex during development. Prog. Neurobiol. (Oxf.). 39:1992;1-43.
15. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA. 94:1997;587-592.
16. Friauf E., McConnell S.K., Shatz C.J. Functional synaptic circuits in the subplate during fetal and early postnatal development of cat visual cortex. J. Neurosci. 10:1990;2601-2613.
17. Greenlund L.J.S., Korsmeyer S.J., Johnson E.M. Role of BCL-2 in the survival and function of developing and mature sympathetic neurons. Neuron. 15:1995;649-661.
18. Gulbinat W., Dupont A., Jablensky A., Jensen O.M., Marsella A., Nakane Y., Sartorius N. Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br. J. Psychiatry. 161:(Suppl. 18):1992;75-85.
19. Harrison P.J. Schizophrenia: a disorder of neurodevelopment? Curr. Opin. Neurobiol. 7:1997;285-289.
20. Harvey I., Ron M.A., Du Boulay G., Wicks D., Lewis S.W., Murray R.M. Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol. Med. 23:1993;591-604.
21. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry. 143:1986;993-997.
22. Jacks T., Weinberg R.A. Cell-cycle control and its watchman. Nature. 381:1996;643-644.
23. Jánicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:1998;9357-9360.
24. Jeste D.V., Gladsjo J.A., Lindamer L.A., Lacro J.P. Medical comorbidity in schizophrenia. Schizophr. Bull. 22:1996;413-430.
25. Jones E.G. Cortical development and thalamic pathology in schizophrenia. Schizophr. Bull. 23:1997;483-501.
26. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
27. Komarova E.A., Chernov M.V., Franks R., Wang K., Armin G., Zelnick C.R., Chin D.M., Bacus S.S., Stark G.R., Gudkov A.V. Transgenic mice with p53-responsive lacZ:p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 16:1997;1391-1400.
28. Kulynych J.J., Luevano L.F., Jones D.W., Weinberger D.R. Cortical abnormality in schizophrenia: an in vivo application of the gyrification index. Biol. Psychiatry. 41:1997;995-999.
29. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
30. Liddle P. Brain imaging. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;Blackwell Science, Cambridge. (Chapter 22).
31. McDonald J.W., Behrens M.I., Chung C., Bhattacharyya T., Choi D.W. Susceptibility to apoptosis is enhanced in immature cortical neurons. Brain Res. 759:1997;228-232.
32. McGrath J.J., van Os J., Hoyos C., Jones P.B., Harvey I., Murray R.M. Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables. Schizophr. Res. 18:1995;9-20.
33. McGrath J.J., Murray R. Riskfactors for schizophrenia: from conception to birth. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;Blackwell Science, Cambridge. (Chapter 12).
34. McNeil T.F. Obstetric factors and perinatal injuries. Tsuang M.T., Simpson J.C. Nosology, Epidemiology and Genetics. Nasralla H.A. Handbook of Schizophrenia. vol. 3:1988;319-345 Elsevier, Amsterdam.
35. Majdan M., Lachance C., Gloster A., Aloyz R., Zeindler C., Bamji S., Bhakar A., Belliveau D., Fawcett J., Miller F.D., Barker P.A. Transgenic mice expressing the intracellular domain of the p75 neurotrophin receptor undergo neuronal apoptosis. J. Neurosci. 17:1997;6988-6998.
36. Miyashita T., Reed J.C. Tumour suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
37. Mortensen P.B. Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr. Scand. 75:1987;585-590.
38. Mortensen P.B. The incidence of cancer in schizophrenic patients. J. Epidemiol. Community Health. 43:1989;43-47.
39. Mortensen P.B. Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr. Scand. 85:1992;390-393.
40. Mortensen P.B. The occurrence of cancer in first admitted schizophrenic patients. Schizophr. Res. 12:1994;185-194.
41. Mortensen P.B., Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br. J. Psychiatry. 163:1993;183-189.
42. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K.I., Nakayama K., Negishi I., Senju S., Zhang Q., Satoshi F., Loh D.Y. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 267:1995;1506-1509.
43. Mrzljak L., Uylings H.B.M., Kostovic I., Van Eden C.G. Prenatal development of neurons in the human prefrontal cortex. J. Comp. Neurol. 271:1988;355-386.
44. Nakane Y., Ohta Y. The example of linkage with a cancer register. ten Horn G.H.M.M., Giel R., Gulbinat W.H., Henderson J.H. Psychiatric Case Registers in Public Health. 1986;240-245 Elsevier, Amsterdam.
45. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 47:1990;1023-1028.
46. L is an antiapoptotic regulator for postnatal CNS neurons. J. Neurosci. 18:1998;1009-1019.
47. Portin P., Alanen Y.O. A critical review of genetic studies of schizophrenia. II. Molecular genetic studies. Acta Psychatr. Scand. 95:1997;73-80.
48. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-400.
49. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., Jacobson M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science. 262:1993;695-700.
50. Raz S., Raz N. Structural brain abnormalities in the major psychoses, a quantitative review of the evidence from computerized imaging. Psychol. Bull. 108:1990;93-108.
51. Sakhi S., Bruce A., Sun N., Tocco G., Baudry M., Schreiber S.S. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA. 91:1994;7525-7529.
52. Shatz C.J., Chun J.J.M., Luskin M.B. The role of the subplate in the development of the mammalian telecephalon. Peters A., Jones E.G. Development and Maturation of Cerebral Cortex. Cerebral Cortex. vol. 7:1988;35-58 Plenum Press, New York.
53. Silos-Santiago I., Greenlund L.J.S., Johnson E.M., Snider W.D. Molecular genetics of neuronal survival. Curr. Opin. Neurobiol. 5:1995;42-49.
54. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
55. Tuck S.P., Crawford L. Characterisation of the human p53 gene promoter. Mol. Cell. Biol. 9:1989;2163-2172.
56. Walker E.F., Savoie T., Davis D. Neuromotor precursors of schizophrenia. Schizophr. Bull. 20:1994;441-451.
57. Watson C.G., Gasser B., Schaefer A., Buranen C., Wold J. Separation of brain damaged from psychiatric patients with ability and personality measures. Clin. Psychol. 37:1981;347-353.
58. Weinberger D. Schizophrenia: from neuropathology to neurodevelopment. Lancet. 346:1995;552-557.
59. Welker W. Why does cerebral cortex fissure and fold? A review of determinants of gyri and sulci. Jones E.G., Peters A. Cerebral Cortex. vol. 8B:1990;3-139 Plenum Press, New York.
60. Wu X., Bayle J.H., Olson D., Levine A.J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1993;1126-1132.
61. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
62. Zipursky R.B., Lim K.O., Sullivan E.V., Brown B.W., Pfefferbaum A. Wide-spread cerebral grey matter volume deficits in schizophrenia. Arch. Gen. Psychiatry. 49:1992;195-205.